{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
INN:lixadesiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02781883: Phase 2 Interventional Recruiting Acute Myeloid Leukemia (AML)
(2016)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01940887: Phase 3 Interventional Terminated Age-Related Macular Degeneration
(2014)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01899729: Phase 2 Interventional Completed Plaque Psoriasis
(2013)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03974113: Phase 3 Interventional Active, not recruiting Hemophilia
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04544956: Phase 2 Interventional Completed Hepatitis B
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01065935: Phase 2 Interventional Completed Respiratory Syncytial Virus Infections
(2010)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00306904: Phase 2 Interventional Completed Diabetic Macular Edema
(2006)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00042081: Phase 3 Interventional Completed Coronary Artery Disease
(2002)
Source URL:
Class:
NUCLEIC ACID
Status:
Designated
Source:
FDA ORPHAN DRUG:173903
Source URL:
Class:
NUCLEIC ACID